Novavax, Inc. (NVAX)
8.525
-0.24
(-2.68%)
USD |
NASDAQ |
Nov 13, 16:00
8.52
0.00 (0.00%)
After-Hours: 19:59
Novavax Gross Profit Margin (Quarterly) : 71.03% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 71.03% |
| June 30, 2026 | 77.70% |
| March 31, 2026 | 78.00% |
| December 31, 2025 | 82.87% |
| September 30, 2025 | 70.20% |
| June 30, 2025 | 94.05% |
| March 31, 2025 | 97.93% |
| December 31, 2024 | 40.81% |
| September 30, 2024 | 30.40% |
| June 30, 2024 | 91.33% |
| March 31, 2024 | 48.00% |
| December 31, 2023 | 48.90% |
| September 30, 2023 | 47.09% |
| June 30, 2023 | 86.98% |
| March 31, 2023 | 73.33% |
| December 31, 2022 | 49.14% |
| September 30, 2022 | 39.70% |
| June 30, 2022 | -49.41% |
| March 31, 2022 | 96.88% |
| December 31, 2021 | 98.35% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 72.05% |
| September 30, 2015 | 57.90% |
| June 30, 2015 | 80.80% |
| March 31, 2015 | 75.10% |
| December 31, 2014 | 57.81% |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | 70.60% |
| Merck & Co., Inc. | 71.65% |
| Pfizer Inc. | 68.17% |
| Amgen, Inc. | 73.09% |
| Editas Medicine, Inc. | 96.29% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -7.31% |
| Return on Invested Capital | -66.14% |
| Profit Margin (Quarterly) | -45.94% |
| Operating Margin (Quarterly) | -41.25% |
| Return on Net Operating Assets | -31.71% |